Novus Biologicals, LLC Sustainability Profile
Novus Biologicals, LLC, headquartered in the United States, is a leading provider of high-quality biological reagents and tools for the life sciences industry. Founded in 2006, the company has established a strong presence in key operational regions, including North America and Europe, by focusing on innovative solutions for research and diagnostics. Specialising in antibodies, proteins, and assay kits, Novus Biologicals distinguishes itself through its commitment to quality and customer support. The company’s extensive product portfolio caters to a diverse range of applications, from basic research to advanced clinical studies. With a reputation for reliability and scientific excellence, Novus Biologicals has achieved notable milestones, including partnerships with prominent research institutions and contributions to significant scientific advancements.
DitchCarbon Score
How does Novus Biologicals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novus Biologicals, LLC's score of 44 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novus Biologicals, LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bio-Techne Corporation, which provides emissions data and climate commitments at a corporate level. As part of its climate strategy, Novus Biologicals inherits reduction initiatives and targets from Bio-Techne Corporation, which is committed to addressing climate change through various sustainability efforts. However, specific reduction targets or achievements for Novus Biologicals are not detailed in the available information. The absence of direct emissions data suggests that Novus Biologicals is still in the process of establishing its own climate commitments or may rely on the broader initiatives set forth by its parent company. The cascading of data from Bio-Techne Corporation indicates a structured approach to sustainability, although specific metrics and targets for Novus Biologicals remain unspecified. Overall, while Novus Biologicals is aligned with the climate commitments of its parent organisation, further details on its individual emissions and reduction strategies are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 2,684,000 | 0,000,000 | 0,000,000 | - |
| Scope 2 | 12,694,000 | 00,000,000 | 00,000,000 | - |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Novus Biologicals, LLC's Industry?
How Carbon Intensive is Novus Biologicals, LLC's Location?
Novus Biologicals, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novus Biologicals, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
